ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 611,40
0,53%
Dow Jones
38 778,10
0,49%
DAX
18 134,56
0,34%
Brent Oil
83,745
-0,18%
Bitcoin
65 282,38
-1,81%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Zynerba Pharmaceuticals Inc (ZYNE)

  7. Zynerba Pharmaceuticals Inc (ZYNE) Actualités

ZYNE

Zynerba Pharmaceuticals (ZYNE)

Zynerba Pharmaceuticals Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ZYNE
DateHeureSourceTitreSymboleSociété
09/02/202401h22Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ZYNEZynerba Pharmaceuticals Inc
19/10/202322h48Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:ZYNEZynerba Pharmaceuticals Inc
12/10/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ZYNEZynerba Pharmaceuticals Inc
11/10/202316h17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZYNEZynerba Pharmaceuticals Inc
11/10/202315h27Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:ZYNEZynerba Pharmaceuticals Inc
11/10/202315h27Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ZYNEZynerba Pharmaceuticals Inc
11/10/202314h56Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:ZYNEZynerba Pharmaceuticals Inc
11/10/202314h31Edgar (US Regulatory)Form SC TO-T/A - Tender offer statement by Third Party: [Amend]NASDAQ:ZYNEZynerba Pharmaceuticals Inc
11/10/202314h17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZYNEZynerba Pharmaceuticals Inc
11/10/202314h00PR Newswire (US)HARMONY BIOSCIENCES COMPLETES ACQUISITION OF ZYNERBA PHARMACEUTICALS AND EXPANDS PIPELINENASDAQ:ZYNEZynerba Pharmaceuticals Inc
04/10/202322h05GlobeNewswire Inc.Important Information for Zynerba Pharmaceuticals Stockholders to Tender Shares for the Harmony Transaction: Process and InstructionsNASDAQ:ZYNEZynerba Pharmaceuticals Inc
29/09/202315h00GlobeNewswire Inc.Zynerba Pharmaceuticals Stockholders Reminded to Tender Shares Before 5:00 PM New York City Time, on Tuesday October 10, 2023NASDAQ:ZYNEZynerba Pharmaceuticals Inc
27/09/202314h00PR Newswire (US)HARMONY BIOSCIENCES ANNOUNCES EXTENSION OF TENDER OFFER TO ACQUIRE ZYNERBA PHARMACEUTICALS, INC.NASDAQ:ZYNEZynerba Pharmaceuticals Inc
14/09/202322h15GlobeNewswire Inc.Zynerba Pharmaceuticals Presents Positive Data from Phase 2 INSPIRE Trial in 22q11.2 Deletion Syndrome at The Society for the Study of Behavioural Phenotypes (SSBP) 25th International Research SymposiumNASDAQ:ZYNEZynerba Pharmaceuticals Inc
05/09/202322h39Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ZYNEZynerba Pharmaceuticals Inc
28/08/202315h05Edgar (US Regulatory)Form SC 14D9 - Solicitation, recommendation statementsNASDAQ:ZYNEZynerba Pharmaceuticals Inc
28/08/202314h23Edgar (US Regulatory)Form SC TO-T - Tender offer statement by Third PartyNASDAQ:ZYNEZynerba Pharmaceuticals Inc
24/08/202323h23Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:ZYNEZynerba Pharmaceuticals Inc
15/08/202322h05Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ZYNEZynerba Pharmaceuticals Inc
14/08/202323h29Edgar (US Regulatory)Form SC TO-C - Written communication relating to an issuer or third partyNASDAQ:ZYNEZynerba Pharmaceuticals Inc
14/08/202323h20Edgar (US Regulatory)Form SC14D9C - Written communication relating to third party tender offerNASDAQ:ZYNEZynerba Pharmaceuticals Inc
14/08/202313h36Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ZYNEZynerba Pharmaceuticals Inc
14/08/202313h30PR Newswire (US)HARMONY BIOSCIENCES TO ACQUIRE ZYNERBA PHARMACEUTICALS, INC.NASDAQ:ZYNEZynerba Pharmaceuticals Inc
08/08/202322h13Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ZYNEZynerba Pharmaceuticals Inc
08/08/202322h05GlobeNewswire Inc.Zynerba Pharmaceuticals Announces New Date for Reconvened Annual MeetingNASDAQ:ZYNEZynerba Pharmaceuticals Inc
28/06/202322h21Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ZYNEZynerba Pharmaceuticals Inc
28/06/202322h05GlobeNewswire Inc.Zynerba Pharmaceuticals Announces Further Adjournment of Annual MeetingNASDAQ:ZYNEZynerba Pharmaceuticals Inc
21/06/202322h07Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ZYNEZynerba Pharmaceuticals Inc
20/06/202313h00GlobeNewswire Inc.Zynerba Pharmaceuticals to Present at the H.C. Wainwright 4th Annual Neuropsychiatry Virtual ConferenceNASDAQ:ZYNEZynerba Pharmaceuticals Inc
15/06/202322h31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ZYNEZynerba Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ZYNE

Dernières Valeurs Consultées

LSE
SESG
Satsusesghanacc
BIT
I09528
XS2675108570 20270929 13...
LSE
AU84
Five Hold.28 A
NASDAQI
VIDSNTR
Strategic Streaming and ...
BOV
VIVT3
TELEF BRASIL ON
BIT
F37953
Vontobel Financial Produ...
TG
A3KWD2
Adecco
EU
SUBA
Schneider 3250% until 06...
AMEX
EELV
Invesco S&P Emerging Mar...
COIN
PLACOUSD
USOTC
CFRUY
Compagnie Financiere Ric... (PK)
USOTC
VCHLF
Value Convergence (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés